NCT06423742

Brief Summary

We aimed to analyze the effect of continuous dual session tDCS in patients with severe chronic subjective tinnitus without any evidence of hearing loss in terms of relief of tinnitus perception, distress, and loudness. Also, we investigated the difference in the maintenance duration of the tinnitus suppression effect of consecutive dual session tDCS compared to other groups followed up for 2 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

10 months

First QC Date

May 16, 2024

Last Update Submit

May 16, 2024

Conditions

Keywords

Transcranial direct current stimulationTinnitus

Outcome Measures

Primary Outcomes (3)

  • Visual analogue scale (VAS) related to tinnitus

    To achieve a more quantitative evaluation of tinnitus reduction, we assessed the Visual Analog Scale (VAS).

    All participants were checked the VAS immediately after the last stimulation of every week for 4 weeks and 8th week (4 weeks after the end of treatment).

  • Tinnitus Handicap Inventory (THI)

    The subjective improvement of tinnitus was evaluated using THI.

    THI was assessed at the 4th and 8th week visits.

  • Beck depression inventory (BDI)

    To assess the association between tinnitus relief and depression, we evaluated the Beck Depression Inventory (BDI).

    THI was assessed at the 4th and 8th week visits.

Study Arms (3)

control

SHAM COMPARATOR

The subjects in control group were received two consecutive sessions of sham stimulation twice a week for 4 weeks (8 sessions in total).

Device: Transcranial direct current stimulation

single-session

ACTIVE COMPARATOR

Patients enrolled to the single-session group received tDCS on one random session out of two consecutive sessions.

Device: Transcranial direct current stimulation

dual-session

EXPERIMENTAL

In the dual-session group, the patients underwent two consecutives tDCS.

Device: Transcranial direct current stimulation

Interventions

The device used for tDCS in this study was DC-Stimulator Plus (NeuroConn GmbH, Ilmenau, Germany). The localization of stimulation area (DLPFC) was determined according to the 10/20 EEG system. Non-conducting, elastic head strap was placed around the head to prevent displacement during stimulation. The recording electrode covered with 5 x 7 cm sized traditional rectangular sponge was soaked with 6-7 mL of 0.9% NaCl saline solution per side and placed on the F3 (anode, left frontal) and F4 (cathode, right frontal) EEG location. Subjects were given 2 mA stimulation intensity for 20 min per session including fade-in and fade-out times for 20 seconds each. Interval between each session was 20 min. Sham procedure has been adopted a Fade In of current, Short Stimulation, Fade Out (FISSFO) protocol that consist of initial ramp up for 20 seconds, 2 mA stimulation for 40 seconds, and 20 seconds for ramp down. To check to impendence, brief current of 110 µA over 15ms every 550ms was delivered.

controldual-sessionsingle-session

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who have experienced subjective tinnitus for over 3 months.
  • Individuals with normal hearing, defined as an average pure tone threshold of less than 25 dB between 0.5-4 kHz, and the presence of the V wave at 30 dBnHL with a difference in V wave latency of less than 0.2 ms in both ears during the ABR test.
  • Individuals with severe tinnitus, as indicated by a Tinnitus Handicap Inventory (THI) score of 58 or higher, and who have been assessed for symptoms of anxiety and depressive mood using the Beck Depression Inventory (BDI) questionnaire.

You may not qualify if:

  • Those requiring treatment for neurological disorders such as epilepsy, migraine, or intracranial masses.
  • Pregnant individuals on the day of providing consent and those with metal-based electric implantable prosthetics.
  • Individuals with objective or somatic tinnitus, auditory hallucinations, unwillingness to provide written consent, or unwillingness to continue the trial, and those who have participated in previous trials involving tDCS for tinnitus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dongtan Sacred Heart Hospital

Hwaseong-si, Gyeonggi-do, 445-170, South Korea

Location

MeSH Terms

Conditions

Tinnitus

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Sung Kyun Kim

    University of Michigan

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The participants were randomly allocated with three different arms (control, single-session, and dual session) using block to balance the size of each group. . Participants who assigned to the control group underwent dual sham stimulation per day, twice a week for 1 month. Patients were received sham and true stimulation once alternately in the single session group and two true stimulation per day in the dual session group for the same period as the control group. All subjects who enrolled this study were given a conventional treatment such as tinnitus retraining therapy, sound therapy using sound generator, and medications like clonazepam, selective serotonin reuptake inhibitors for patients who wanted to take for relief of symptoms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2024

First Posted

May 21, 2024

Study Start

December 15, 2021

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

May 21, 2024

Record last verified: 2024-05

Locations